| RS369566535 |
AARS2
|
Health Risk |
Likely pathogenic |
— |
| RS369566552 |
KMT2A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS369567469 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Alport syndrome, Autosomal dominant Alport syndrome |
| RS369568420 |
FBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Marfan syndrome |
| RS369568820 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS369569464 |
KEL
|
Health Risk |
Pathogenic |
KELL-NULL PHENOTYPE, KELL-NULL PHENOTYPE |
| RS369571582 |
TTC29
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS369572563 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS369573693 |
COQ8B
|
Health Risk |
Pathogenic |
Nephrotic syndrome, type 9 |
| RS369574115 |
TYMP
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS369574719 |
GBE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adult polyglucosan body disease, Glycogen storage disease |
| RS369575243 |
GPD1
|
Health Risk |
Pathogenic |
Transient infantile hypertriglyceridemia and hepatosteatosis, Transient infantile hypertriglyceridemia and hepatosteatosis |
| RS369575989 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Alport syndrome, COL4A3-related disorder |
| RS369576099 |
MLH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS369576300 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS369577952 |
ALS2
|
Health Risk |
Pathogenic |
Infantile-onset ascending hereditary spastic paralysis, Amyotrophic lateral sclerosis type 2 |
| RS369579749 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS369580755 |
PRDM5
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, Cardiovascular phenotype |
| RS369580836 |
EGFR
|
Health Risk |
Conflicting classifications of pathogenicity |
EGFR-related lung cancer, Hereditary cancer-predisposing syndrome |
| RS369581570 |
MYH9
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss |
| RS369582237 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Lynch syndrome 4 |
| RS369583084 |
EOGT
|
Health Risk |
Pathogenic |
Adams-Oliver syndrome 4, Adams-Oliver syndrome 4 |
| RS369583279 |
BLM
|
Health Risk |
Pathogenic/Likely pathogenic |
Bloom syndrome, Hereditary cancer-predisposing syndrome |
| RS369583316 |
PCDH15
|
Health Risk |
Likely pathogenic |
— |
| RS369583365 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Melnick-Needles syndrome, Heterotopia |
| RS369583604 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS369583884 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Cardiomyopathy |
| RS369584932 |
GEN1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS369585190 |
CPLANE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 17, Joubert syndrome 17 |
| RS369585356 |
EGFR
|
Health Risk |
Conflicting classifications of pathogenicity |
EGFR-related lung cancer, Hereditary cancer-predisposing syndrome |
| RS369585835 |
BCOR
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Oculofaciocardiodental syndrome |
| RS369586175 |
PCNT
|
Health Risk |
Conflicting classifications of pathogenicity |
PCNT-related disorder, Inborn genetic diseases |
| RS369586235 |
NOTCH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hajdu-Cheney syndrome, NOTCH2-related disorder |
| RS369587906 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS369587937 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS369588002 |
TWNK
|
Health Risk |
Conflicting classifications of pathogenicity |
Perrault syndrome 5, Perrault syndrome |
| RS369588299 |
TMEM43
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 5, Cardiovascular phenotype |
| RS369588398 |
KMT2B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS369588942 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS369590240 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Neurofibromatosis |
| RS369590382 |
SUCLA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria |
| RS369590424 |
ZFYVE26
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 15, Hereditary spastic paraplegia 15 |
| RS369590506 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS369591434 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS369591910 |
COL7A1
|
Health Risk |
Pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS369594816 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS369596004 |
ENG
|
Health Risk |
Pathogenic |
Hereditary hemorrhagic telangiectasia, Hereditary hemorrhagic telangiectasia |
| RS369596190 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS369597903 |
SCP2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS369598638 |
NGLY1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital disorder of deglycosylation, Inborn genetic diseases |
| RS369600509 |
NPHP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis, Inborn genetic diseases |
| RS369600555 |
HSD17B4
|
Health Risk |
Conflicting classifications of pathogenicity |
Perrault syndrome, Bifunctional peroxisomal enzyme deficiency |
| RS369600566 |
SOD1
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS369601921 |
LHCGR
|
Health Risk |
Conflicting classifications of pathogenicity |
Gonadotropin-independent familial sexual precocity, Leydig cell agenesis |
| RS369602025 |
CTSD
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis 10, Neuronal ceroid lipofuscinosis |
| RS369602540 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS369603431 |
SLC3A1
|
Health Risk |
Pathogenic |
Cystinuria, Cystinuria |
| RS369603655 |
TBX6
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS369603835 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS369605412 |
FRAS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fraser syndrome 1, Fraser syndrome 1 |
| RS369606098 |
FGA
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital afibrinogenemia, Familial visceral amyloidosis |
| RS369606261 |
TECRL
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS369606279 |
CDH23
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS369606728 |
RP1L1
|
Health Risk |
Conflicting classifications of pathogenicity |
Occult macular dystrophy, Occult macular dystrophy |
| RS369607332 |
DYSF
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS369607686 |
PDGFRA
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Hereditary cancer-predisposing syndrome |
| RS369608621 |
PIGA
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple congenital anomalies-hypotonia-seizures syndrome 2, Inborn genetic diseases |
| RS369608927 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, Hypogonadotropic hypogonadism 5 with or without anosmia |
| RS369609034 |
DOCK6
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS369609245 |
BMPR1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Acromesomelic dysplasia 3, Type A2 brachydactyly |
| RS369610397 |
RYR1
|
Health Risk |
Likely pathogenic |
RYR1-related disorder, Central core myopathy |
| RS369610829 |
TYR
|
Health Risk |
Pathogenic |
SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN |
| RS369610897 |
SUCLG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial DNA depletion syndrome 9, Mitochondrial DNA depletion syndrome 9 |
| RS369612664 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS369613619 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Colorectal cancer |
| RS369614706 |
DYNC2H1
|
Health Risk |
Pathogenic/Likely pathogenic |
Jeune thoracic dystrophy, Asphyxiating thoracic dystrophy 3 |
| RS369615430 |
PAX2
|
Health Risk |
Likely pathogenic |
Focal segmental glomerulosclerosis 7, Focal segmental glomerulosclerosis 7 |
| RS369615995 |
AHNAK2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS369616302 |
PLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Angioedema, hereditary |
| RS369619415 |
LSS
|
Health Risk |
Pathogenic |
— |
| RS369619683 |
TRPS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Trichorhinophalangeal syndrome |
| RS369620087 |
SLC26A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephrolithiasis, calcium oxalate |
| RS369620088 |
TBK1
|
Health Risk |
Pathogenic |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 4, Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 |
| RS369620344 |
MYH14
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, MYH14-related disorder |
| RS369621159 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa simplex 5C, with pyloric atresia |
| RS369621601 |
NOTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adams-Oliver syndrome 5, Familial thoracic aortic aneurysm and aortic dissection |
| RS369623392 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Dilated cardiomyopathy 1G |
| RS369624032 |
DHCR24
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS369626030 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS369626133 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-onset myopathy with fatal cardiomyopathy, Dilated cardiomyopathy 1G |
| RS369626489 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS369626505 |
ABHD12
|
Health Risk |
Conflicting classifications of pathogenicity |
PHARC syndrome, PHARC syndrome |
| RS369626832 |
TNFRSF13C
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency, common variable |
| RS369626956 |
CACNA1D
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS369629290 |
CA5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency, Inborn genetic diseases |
| RS369629444 |
AAAS
|
Health Risk |
Likely pathogenic |
— |
| RS369629509 |
BLM
|
Health Risk |
Conflicting classifications of pathogenicity |
Bloom syndrome, Hereditary cancer-predisposing syndrome |
| RS369629619 |
RYR3
|
Health Risk |
Conflicting classifications of pathogenicity |
Epileptic encephalopathy, Epileptic encephalopathy |
| RS369630361 |
IL11RA
|
Health Risk |
Likely pathogenic |
Craniosynostosis and dental anomalies, Craniosynostosis and dental anomalies |
| RS369630836 |
CACNA1H
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic generalized epilepsy, Hyperaldosteronism |